Administration of anti-CD8 antibody significantly reduced CD8+ cells in spleens and tumor-bearing SMG tissues in Atg5flox/flox mice, while the percentage of CD4+ cells remained unaffected (Figure S5B). Here, CD8A is linked to neoplasm.